A detailed history of Avalon Investment & Advisory transactions in Bio Techne Corp stock. As of the latest transaction made, Avalon Investment & Advisory holds 9,716 shares of TECH stock, worth $732,392. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,716
Previous 11,310 14.09%
Holding current value
$732,392
Previous $937,000 23.16%
% of portfolio
0.02%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $114,162 - $138,072
-1,594 Reduced 14.09%
9,716 $720,000
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $716,107 - $3.13 Million
8,877 Added 364.86%
11,310 $937,000
Q3 2022

Nov 01, 2022

SELL
$282.54 - $391.85 $18,930 - $26,253
-67 Reduced 2.68%
2,433 $691,000
Q2 2022

Aug 10, 2022

SELL
$322.67 - $449.65 $166,175 - $231,569
-515 Reduced 17.08%
2,500 $867,000
Q1 2022

May 17, 2022

SELL
$353.85 - $487.79 $16,277 - $22,438
-46 Reduced 1.5%
3,015 $1.31 Million
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $188,389 - $216,849
-413 Reduced 11.89%
3,061 $1.58 Million
Q3 2021

Nov 08, 2021

BUY
$444.87 - $538.88 $23,578 - $28,560
53 Added 1.55%
3,474 $1.68 Million
Q2 2021

Jul 29, 2021

SELL
$387.35 - $450.26 $1,162 - $1,350
-3 Reduced 0.09%
3,421 $1.54 Million
Q1 2021

May 13, 2021

BUY
$314.62 - $411.0 $45,619 - $59,595
145 Added 4.42%
3,424 $1.31 Million
Q4 2020

Feb 08, 2021

BUY
$246.9 - $321.87 $150,855 - $196,662
611 Added 22.9%
3,279 $1.04 Million
Q3 2020

Nov 04, 2020

BUY
$232.22 - $282.96 $355,064 - $432,645
1,529 Added 134.24%
2,668 $661,000
Q2 2020

Aug 07, 2020

BUY
$185.43 - $279.56 $211,204 - $318,418
1,139 New
1,139 $301,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.96B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Avalon Investment & Advisory Portfolio

Follow Avalon Investment & Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.